Back to search

Article

Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson’s disease: A case report

2023-03-08

Abstract excerpt

<h4>Background: </h4> Evidence is limited regarding the optimal therapeutic approach for neuropsychiatric symptoms associated with Parkinson’s disease dementia (PDD). Selective serotonin reuptake inhibitors (SSRIs) are widely used for mood disorders and behavioral symptoms in older adults with cognitive impairment, but they have limited efficacy in patients with PDD. The effect of SSRIs on hemostasis is also uncle...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
03839518-09fc-52ea-bd47-06e287a41847
DOI
10.21203/rs.3.rs-2608876/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson’s disease: A case reportDOI 10.21203/rs.3.rs-2608876/v1
Understanding Drug-Induced Movement Disorders: Causes, Symptoms, and TreatmentSemantic proximity
High Rates of Blood Transfusion Associated with Parkinson’s DiseaseSemantic proximity
Valproic Acid: Special Considerations and Targeted Monitoring.Semantic proximity
Prevalence and Impact of Orthostatic Hypotension in Parkinson's Disease: A Systematic Review and Meta-AnalysisSemantic proximity
Anxiety Disorders in Parkinson’s Disease: A Narrative Review of Epidemiology and ManagementSemantic proximity
Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disordersSemantic proximity
A Study of Brain MRI Findings in CKD Patients with and without ParkinsonismSemantic proximity
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserinSemantic proximity
Dyskinesia after Levetiracetam Therapy: A Case ReportSemantic proximity
Diagnosis and treatment of neurotransmitter-related disorders.Semantic proximity
Case Report: Psychiatric comorbidity in the setting of encephalomalacia and gliosisSemantic proximity
[Treatments for Parkinson's Disease -Essential Knowledge for General Physicians - Topics: III. Recommended Usage of New Antiparkinson Drugs].Semantic proximity
Select a neighboring publication to make it the new centre.